DESyne in Routine Clinical Practice

Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice

NCT03967158 ·Status: ACTIVE_NOT_RECRUITING

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents

NCT00638794 ·Status: COMPLETED

Prospective Assessment of Efficacy and Safety of Drug Eluting Stents

NCT02313038 ·Status: COMPLETED

Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)

NCT05656118 ·Status: ACTIVE_NOT_RECRUITING

The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions

NCT05033964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Orsiro™ Drug Eluting Stent in Routine Clinical Practice

NCT02039739 ·Status: COMPLETED

IRIS-Synergy Cohort in the IRIS-DES Registry

NCT02720419 ·Status: ACTIVE_NOT_RECRUITING

Drug-Coated Balloon in Combination With New Generation Drug-Eluting Stent for de Novo Diffuse Disease Treatment

NCT03939468 ·Status: UNKNOWN

Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)

NCT05448625 ·Status: COMPLETED

Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus

NCT01293773 ·Status: WITHDRAWN ·Phase: PHASE4

DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold

NCT03074305 ·Status: WITHDRAWN ·Phase: NA

Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment

NCT03899818 ·Status: COMPLETED ·Phase: NA

The Clinical Efficacy and Safety of Drug-coated Balloon

NCT05133921 ·Status: COMPLETED

Genoss DES Prospective Multicenter Registry

NCT03045913 ·Status: COMPLETED

Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial

NCT03589157 ·Status: UNKNOWN ·Phase: NA

International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions

NCT01373502 ·Status: COMPLETED ·Phase: NA

Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients

NCT03842813 ·Status: UNKNOWN

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease

NCT03376646 ·Status: COMPLETED ·Phase: NA

Joint Inflation With Nominal-pressure and Stability Approach in DES Optimization

NCT06013007 ·Status: COMPLETED ·Phase: NA

Dexamethasone-Eluting Stent in Acute Coronary Syndrome to Prevent Restenosis

NCT00190099 ·Status: COMPLETED ·Phase: PHASE4

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent

NCT00485030 ·Status: COMPLETED ·Phase: PHASE4

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT07190690 ·Status: RECRUITING ·Phase: NA

Intimal Hyperplasia Evaluated by Optical Coherence Tomography (OCT) in de Novo Coronary Lesions Treated by Drug-eluting Balloon and Bare-metal Stent

NCT01057563 ·Status: UNKNOWN ·Phase: PHASE4

Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)

NCT01078051 ·Status: TERMINATED ·Phase: PHASE4

Vascular Healing of DES at 3 Months

NCT01391871 ·Status: COMPLETED